Skip to main content
Clinical Trials/NL-OMON22925
NL-OMON22925
Recruiting
Not Applicable

Effectivity of Neurofeedback in youth with AD(H)D-problems and comorbid disorders: a randomized controlled trial.

Zon MW0 sites150 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
eurofeedbackADHDEEG
Sponsor
Zon MW
Enrollment
150
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Zon MW

Eligibility Criteria

Inclusion Criteria

  • \* Male \* Between 12 and 24 years old \*A positive screen on the screeningslist ADHD of Kooij (clinical: more than six points on one of the scales or subclinical: four or more points on one of the scales) or a DSM IV diagnosis ADHD \*Dutch as native language \*Diagnosed with a comorbid disorder.

Exclusion Criteria

  • \*A total IQ\-score \< 80 points on the WAIS or WISC intelligence scales \*An instable EEG\-pattern (epilepsy) \*Having a medical condition that account for attentional problems or hyperactivity (organic brain damage), presentation of a psychotic disorder or schizophrenia.

Outcomes

Primary Outcomes

Not specified

Similar Trials